UNICA IRIS Institutional Research Information System

SIMOLA, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 170.877
NA - Nord America 8.276
AS - Asia 2.655
SA - Sud America 502
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 6
Totale 182.379
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 169.173
US - Stati Uniti d'America 8.183
CN - Cina 1.203
SG - Singapore 989
UA - Ucraina 483
SE - Svezia 439
BR - Brasile 423
DE - Germania 210
VN - Vietnam 172
GB - Regno Unito 165
FI - Finlandia 142
FR - Francia 69
KR - Corea 57
CA - Canada 53
HK - Hong Kong 49
IN - India 47
PL - Polonia 47
AR - Argentina 29
NL - Olanda 27
MX - Messico 25
RU - Federazione Russa 23
JP - Giappone 19
BD - Bangladesh 18
ES - Italia 18
BE - Belgio 15
AT - Austria 13
MA - Marocco 13
ZA - Sudafrica 13
CH - Svizzera 12
EG - Egitto 12
IQ - Iraq 12
CO - Colombia 11
CZ - Repubblica Ceca 11
EC - Ecuador 11
ID - Indonesia 9
TR - Turchia 9
UZ - Uzbekistan 9
EU - Europa 8
VE - Venezuela 8
IR - Iran 7
PE - Perù 7
PK - Pakistan 7
CL - Cile 6
IL - Israele 6
LT - Lituania 6
SA - Arabia Saudita 6
IE - Irlanda 5
JO - Giordania 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
NI - Nicaragua 4
TW - Taiwan 4
DO - Repubblica Dominicana 3
KE - Kenya 3
NG - Nigeria 3
PA - Panama 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BY - Bielorussia 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
KZ - Kazakistan 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
TH - Thailandia 2
TJ - Tagikistan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
PH - Filippine 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 182.377
Salva come PNG Salva come JPEG
Città #
Cagliari 164.816
Uta 3.886
Fairfield 1.013
Woodbridge 732
Ashburn 701
Chandler 594
Dallas 479
Houston 434
Singapore 401
Ann Arbor 396
Seattle 369
Wilmington 354
Cambridge 352
Boardman 319
Beijing 292
Nyköping 289
Jacksonville 244
New York 217
Dearborn 192
Santa Clara 115
Nanjing 113
Shanghai 101
Los Angeles 99
Boston 92
Hangzhou 92
Dong Ket 68
Hefei 59
Helsinki 52
Seoul 52
Buffalo 50
San Diego 50
Hong Kong 44
Munich 44
Guangzhou 37
Ho Chi Minh City 37
The Dalles 35
Shenyang 34
Council Bluffs 33
Toronto 32
London 29
Milan 29
Redondo Beach 29
São Paulo 28
Norwalk 27
Nanchang 25
Redwood City 25
Tianjin 24
Brooklyn 23
Falls Church 23
Chicago 22
Hebei 22
Sassari 20
Sestu 18
Warsaw 18
Cracow 17
Atlanta 16
Hanoi 16
Mountain View 16
Phoenix 15
Rome 15
Changsha 14
Verona 14
Washington 14
Brussels 13
Montreal 13
Tokyo 13
Jiaxing 12
Jinan 12
Ningbo 12
Orange 12
Padova 12
Zhengzhou 12
Chennai 11
Columbus 11
Curitiba 11
Mexico City 11
Rio de Janeiro 10
Wuhan 10
Auburn Hills 9
Da Nang 9
Frankfurt am Main 9
Kunming 9
Oristano 9
Amsterdam 8
Belo Horizonte 8
Casablanca 8
Dhaka 8
Genova 8
Lappeenranta 8
Nuremberg 8
Porto Alegre 8
Pune 8
San Francisco 8
San Mateo 8
Stockholm 8
Tashkent 8
Turku 8
Brasília 7
Chengdu 7
Düsseldorf 7
Totale 178.171
Salva come PNG Salva come JPEG
Nome #
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 4.256
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.592
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.511
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence 3.445
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats 3.350
Role of Adenosine in the basal Ganglia 3.323
The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats 3.129
Antagonism of Adenosine A1 or A2A Receptors Amplifies the Effects of 3,4-Methylendioxymethamphetamine (MDMA) on Glial Activation in the Mouse Brain: Relevance to Caffeine-MDMA Interactions 3.067
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway 2.983
Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration? 2.966
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms 2.913
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 2.870
Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: Implications for the study of the affective properties of drugs of abuse 2.803
Modulation of rat 50-kHz ultrasonic vocalizations by glucocorticoid signaling: possible relevance to reward and motivation 2.784
Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia 2.722
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain 2.675
Methylxanthines and drug dependence: interactions and toxicity 2.664
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease 2.625
Amphetamine usage, misuse, and addiction processes: an overview 2.613
Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies 2.562
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility 2.496
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease 2.495
Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage 2.480
Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity 2.473
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease 2.467
Influence of dopamine transmission in the medial prefrontal cortex and dorsal striatum on the emission of 50-kHz ultrasonic vocalizations in rats treated with amphetamine: Effects on drug-stimulated and conditioned calls 2.459
Involvement of Glutamate NMDA Receptors in the Acute, Long-Term, and Conditioned Effects of Amphetamine on Rat 50kHz Ultrasonic Vocalizations 2.402
Activation of adenosine A2A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation 2.376
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies 2.307
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease 2.269
MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex 2.224
Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs 2.162
Emission of categorized 50-kHz ultrasonic vocalizations in rats repeatedly treated with amphetamine or apomorphine: possible relevance to drug-induced modifications in the emotional state 2.082
Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons 2.069
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 2.056
Preface [ to The Adenosinergic System. A Non-Dopaminergic Target in Parkinson’s Disease] 1.957
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 1.942
Repeated amphetamine administration and long-term effects on 50-kHz ultrasonic vocalizations: possible relevance to the motivational and dopamine-stimulating properties of the drug 1.940
Role of movement in long-term basal ganglia changes: implications for abnormal motor responses 1.923
Ultrasonic vocalizations as a tool in studying emotional states in rodent models of social behavior and brain disease 1.906
Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective? 1.839
Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations 1.805
Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson’s Disease 1.784
Increased emissions of 50-kHz ultrasonic vocalizations in hemiparkinsonian rats repeatedly treated with dopaminomimetic drugs: A potential preclinical model for studying the affective properties of dopamine replacement therapy in Parkinson's disease 1.772
Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions 1.769
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.754
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.746
null 1.722
Repertoire and Biological Function of Ultrasonic Vocalizations in Adolescent and Adult Rats 1.689
Effect of long-term administration of antiretroviral drugs (Tenofovir and Nevirapine) on neuroinflammation and neuroplasticity in mouse hippocampi 1.666
null 1.651
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat 1.602
Effects of Psychostimulants on Rat Emotional States and Emission of Ultrasonic Vocalizations 1.513
The sweet road to Parkinson's disease 1.501
Ultrasonic vocalizations in rats: a tool for the investigation of psychoactive drugs and neuropsychiatric conditions 1.452
Adenosine A2A receptors: localization and function 1.448
Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences 1.442
Gender specific reduction of hypermotility by sub-chronic methylphenidate or atomoxetine in SH rats, an animal model of ADHD 1.414
Rat 50-kHz ultrasonic vocalizations as a tool in studying neurochemical mechanisms that regulate positive emotional states 1.386
Adenosine signaling in the basal ganglia 1.271
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1 or D2 dopamine receptor agonists 1.254
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats 1.252
Rat ultrasonic vocalizations and behavioral neuropharmacology: from the screening of drugs to the study of disease 1.234
null 1.194
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats 1.179
The 6-hydroxydopamine model of Parkinson's disease 1.158
Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA 1.157
Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice 1.149
Adenosine A2A receptor antagonist treatment of Parkinson’s disease 1.125
Adenosine A2A receptor antagonists and Parkinson’s disease: state of the art and future directions 1.108
null 1.108
In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice 1.079
A2A receptor antagonism and dyskinesia in Parkinson’s Disease 1.071
Caffeine Consumption and Changes in the Function of Dopaminergic Transmission: Evidence of a Hyperdopaminergic State in Rats Subchronically Treated with Caffeine 1.055
null 1.012
Perinatal asphyxia: CNS development and deficits with delayed onset 1.006
Methylxanthines and Drug Dependence: A Focus on Interactions with Substances of Abuse 1.003
Anxyiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity 995
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 984
null 967
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 936
Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences 931
Lack of drug- and cue-stimulated emissions of ultrasonic vocalizations in C57BL/6 J mice repeatedly treated with amphetamine 925
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists 896
Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins 892
Priming of rotational behavior by a dopamine receptor agonist in hemiparkinsonian rats: Movement-dependent induction 867
What do you see as the main priorities, Opportunities, and Challenges in Caffeine Research in the Next Five Years? 856
Effects of combination antiretroviral drugs (cART) on hippocampal neuroplasticity in female mice 847
Association between novel object recognition/spontaneous alternation behavior and emission of ultrasonic vocalizations in rats: Possible relevance to the study of memory 815
Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats 755
Acute and long-term effects elicited by psychoactive drugs on 50-kHz ultrasonic vocalizations in rats: development of a new experimental tool for the study of drug-mediated reward. 751
Caffeine 739
Editorial of special issue – Synthetic psychoactive substances and neurological diseases: Toxic and therapeutic effects 704
Can dietary substances protect against Parkinson's disease? The case of caffeine 700
null 685
Increase of dopamine D2(High) receptors in the striatum of rats sensitized to caffeine motor effects 612
null 594
Influence of acute caffeine on 50-kHz ultrasonic vocalizations in male adult rats and relevance to caffeine-mediated psychopharmacological effects 573
Dopaminergic Treatments for Parkinson’s Disease: Light and Shadows 564
Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis 552
Totale 174.848
Salva come PNG Salva come JPEG
Categoria #
all - tutte 227.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.831
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116.638 0 0 0 0 0 4.244 3.199 2.128 1.064 2.491 1.964 1.548
2021/202210.467 1.147 719 656 770 740 687 720 604 759 1.075 1.110 1.480
2022/202317.432 1.649 2.449 1.978 1.467 1.488 1.707 837 1.260 1.134 1.264 1.513 686
2023/202415.716 713 740 548 865 1.643 2.554 2.484 1.094 709 1.113 1.602 1.651
2024/202523.526 4.557 4.795 3.957 3.215 1.708 1.964 2.040 165 355 273 309 188
2025/20263.467 776 356 893 658 729 55 0 0 0 0 0 0
Totale 183.105